Umeå University's logo

umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Salpingectomy versus tubal occlusion in laparoscopic sterilisation (SALSTER): a national register-based randomised non-inferiority trial
Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Vise andre og tillknytning
2024 (engelsk)Inngår i: The Lancet Regional Health: Europe, E-ISSN 2666-7762, Vol. 45, artikkel-id 101026Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Background: Opportunistic salpingectomy to reduce ovarian cancer incidence has become increasingly common despite the lack of randomised trials investigating its safety. In SALSTER, we tested whether salpingectomy for laparoscopic sterilisation is non-inferior to tubal occlusion regarding complications up to eight weeks postoperatively.

Methods: SALSTER is a register-based randomised non-inferiority trial in which 41 gynaecological departments in Sweden participated. After being reported to The Swedish National Quality Register of Gynaecological Surgery (GynOp) for laparoscopic sterilisation, women aged <50 years received study information and could consent to participation online. If eligible, randomisation was performed by the examining/operating gynaecologist before surgery, with stratification for centre, and allocation 1:1 to salpingectomy or tubal occlusion. Blinding was attempted for patients but was impossible for surgeons. The first primary outcome, any complication up to eight weeks postoperatively, was routinely reported in GynOp through physician assessment of patient questionnaires, medical records and personal contact. Complications up to eight weeks postoperatively, a primary safety outcome, were analysed in the per-protocol population. The non-inferiority margin for the difference in the absolute risk of complications was defined as ten percentage points. Missing data were handled using multiple imputation. SALSTER was registered at ClinicalTrials.gov (NCT03860805).

Findings: Between April 4, 2019, and March 31, 2023, 539 women were randomised to salpingectomy and 527 to tubal occlusion. In the salpingectomy and tubal occlusion arms, 40 and 18 women discontinued their participation in the trial and another 26 and 10 did not receive the allocated surgery, respectively. Calculated on imputed data, any complication up to eight weeks postoperatively occurred in 8.1% (38.5/473) of patients after salpingectomy and in 6.2% (31.0/499) of patients after tubal occlusion. The risk difference was 1.9 percentage points (95% confidence interval −1.4 to 5.3).

Interpretation: Laparoscopic salpingectomy is non-inferior to tubal occlusion regarding complication rates up to eight weeks postoperatively. Funding: This research was funded by the Swedish Cancer Society, the Lena Wäppling foundation, the Swedish state under the ALF-agreement, Umeå University, County of Värmland, and Gothenburg Society of Medicine.

sted, utgiver, år, opplag, sider
Elsevier, 2024. Vol. 45, artikkel-id 101026
Emneord [en]
Epithelial ovarian cancer, Laparoscopic sterilisation, Opportunistic salpingectomy, Randomised controlled trial, Tubal ligation, Tubal occlusion
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-229645DOI: 10.1016/j.lanepe.2024.101026ISI: 001329621200001Scopus ID: 2-s2.0-85203062510OAI: oai:DiVA.org:umu-229645DiVA, id: diva2:1897967
Forskningsfinansiär
Swedish Cancer SocietyUmeå UniversityRegion VärmlandTilgjengelig fra: 2024-09-16 Laget: 2024-09-16 Sist oppdatert: 2025-02-11bibliografisk kontrollert

Open Access i DiVA

fulltext(317 kB)98 nedlastinger
Filinformasjon
Fil FULLTEXT02.pdfFilstørrelse 317 kBChecksum SHA-512
b6dcd354c89fe1181c88f729e7a7904f7c1dccf7b5ed6a082f5b8300f6bc988ee85ff40b4cef7278eb682166df99c616eea7849ec3e2014a17e3869245ae2e4a
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstScopus

Person

Liv, PerIdahl, Annika

Søk i DiVA

Av forfatter/redaktør
Liv, PerIdahl, Annika
Av organisasjonen
I samme tidsskrift
The Lancet Regional Health: Europe

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 108 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
urn-nbn

Altmetric

doi
urn-nbn
Totalt: 537 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf